Renaissance Technologies’s Revance Therapeutics, Inc. RVNC Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-459,300
Closed -$2.38M 3985
2024
Q3
$2.38M Sell
459,300
-112,700
-20% -$585K ﹤0.01% 1897
2024
Q2
$1.47M Buy
572,000
+198,300
+53% +$510K ﹤0.01% 2082
2024
Q1
$1.84M Buy
+373,700
New +$1.84M ﹤0.01% 2084
2023
Q4
Sell
-178,500
Closed -$2.05M 4219
2023
Q3
$2.05M Sell
178,500
-32,017
-15% -$367K ﹤0.01% 1843
2023
Q2
$5.33M Buy
+210,517
New +$5.33M 0.01% 1399
2020
Q2
Sell
-472,700
Closed -$7M 3832
2020
Q1
$7M Sell
472,700
-204,773
-30% -$3.03M 0.01% 1374
2019
Q4
$11M Sell
677,473
-198,900
-23% -$3.23M 0.01% 1385
2019
Q3
$11.4M Sell
876,373
-454,600
-34% -$5.91M 0.01% 1306
2019
Q2
$17.3M Buy
1,330,973
+428,900
+48% +$5.56M 0.02% 1052
2019
Q1
$14.2M Buy
902,073
+330,200
+58% +$5.2M 0.01% 1169
2018
Q4
$11.5M Buy
571,873
+395,419
+224% +$7.96M 0.01% 1216
2018
Q3
$4.39M Sell
176,454
-58,746
-25% -$1.46M ﹤0.01% 1890
2018
Q2
$6.46M Buy
235,200
+85,300
+57% +$2.34M 0.01% 1613
2018
Q1
$4.62M Buy
149,900
+61,944
+70% +$1.91M 0.01% 1867
2017
Q4
$3.14M Buy
87,956
+8,164
+10% +$292K ﹤0.01% 2086
2017
Q3
$2.2M Sell
79,792
-30,581
-28% -$842K ﹤0.01% 2255
2017
Q2
$2.91M Buy
+110,373
New +$2.91M ﹤0.01% 2048
2016
Q1
Sell
-215,900
Closed -$7.38M 3562
2015
Q4
$7.38M Buy
215,900
+128,400
+147% +$4.39M 0.02% 1191
2015
Q3
$2.6M Sell
87,500
-41,000
-32% -$1.22M 0.01% 1830
2015
Q2
$4.11M Buy
128,500
+63,091
+96% +$2.02M 0.01% 1569
2015
Q1
$1.36M Buy
+65,409
New +$1.36M ﹤0.01% 2146